bioA Resolved · high auto-curated

H37Rv Rv1568 · MTBC0 mtbc0_001676 · 437 aa · 1787356–1788669 MTBC0 (+) · RefSeq NP_216084.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)adenosylmethionine--8-amino-7-oxononanoate aminotransferase BioA
MTBC0 PGAP re-annotationadenosylmethionine--8-amino-7-oxononanoate transaminase
Revised (this work)Adenosylmethionine--8-amino-7-oxononanoate transaminase. Pfam: Aminotran_3 (PF00202.28).
Functional category (TubercuList)intermediary metabolism and respiration

Curation note: P16.23 (phase135, 2026-08-17): couche tss ajoutee (leaderless=False). P49.1 (phase233, 2026-09-15): couche tss re-clee (leaderless=False).

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 19 publications

19 TB publications mention this gene. 19 publications discuss this gene (count verified against title and abstract text). Queried separately, 22 records carry a M. tuberculosis context and 1 a non-TB mycobacterial context (no species could be confirmed in the 1-record verified sample). The three counts come from three distinct PubMed queries (the total is text-verified, the context counts are raw query volumes), so they neither partition the total nor need to add up to it.

5 of 19: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. doi:10.1021/acs.jmedchem.5c03325 2026
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for Tuberculosis. doi:10.1101/2025.09.24.678246 2025
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies. doi:10.1016/j.ijbiomac.2024.133285 2024
Screening of marine natural products for potential inhibitors targeting biotin biosynthesis pathway in Mycobacterium tuberculosis. doi:10.1080/07391102.2022.2135596 2023
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. doi:10.3390/antibiotics11070831 2022
26 records returned by the alias sweep (a separate sweep from the 19 above; both are shown, neither is exhaustive)

Searched as: Rv1568, bioA, Mb1595, ML1216, MMAR_2383, MSMEG_3188, MAB_2688c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. doi:10.1021/acs.jmedchem.5c03325 names it J Med Chem 2026
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for Tuberculosis. doi:10.1101/2025.09.24.678246 names it bioRxiv 2025
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies. doi:10.1016/j.ijbiomac.2024.133285 Int J Biol Macromol 2024
Screening of marine natural products for potential inhibitors targeting biotin biosynthesis pathway in Mycobacterium tuberculosis. doi:10.1080/07391102.2022.2135596 J Biomol Struct Dyn 2023
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. doi:10.3390/antibiotics11070831 Antibiotics (Basel) 2022
Mimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogens. doi:10.1038/s41564-019-0595-2 Nat Microbiol 2020
Mycobacterium bovis BCG Surface Antigens Expressed under the Granuloma-Like Conditions as Potential Inducers of the Protective Immunity. doi:10.1155/2019/9167271 Int J Microbiol 2019
Identification of Mycobacterium tuberculosis BioA inhibitors by using structure-based virtual screening. doi:10.2147/DDDT.S144240 names it Drug Des Devel Ther 2018
An attenuated quadruple gene mutant of Mycobacterium tuberculosis imparts protection against tuberculosis in guinea pigs. doi:10.1242/bio.029546 Biol Open 2018
Fragment-based approaches to TB drugs. doi:10.1017/S0031182016001876 Parasitology 2018
Synthesis of a 3-Amino-2,3-dihydropyrid-4-one and Related Heterocyclic Analogues as Mechanism-Based Inhibitors of BioA, a Pyridoxal Phosphate-Dependent Enzyme. doi:10.1021/acs.joc.7b00847 names it J Org Chem 2017
bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs. doi:10.1371/journal.pone.0179513 names it PLoS One 2017
Structure-Based Optimization of Pyridoxal 5'-Phosphate-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis. doi:10.1021/acs.jmedchem.7b00189 names it J Med Chem 2017
Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation. doi:10.1021/jacs.7b00962 J Am Chem Soc 2017
In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA). doi:10.2147/DDDT.S119930 names it Drug Des Devel Ther 2017
Fragment-based exploration of binding site flexibility in Mycobacterium tuberculosis BioA. doi:10.1021/acs.jmedchem.5b00092 names it J Med Chem 2015
Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis. doi:10.1016/j.chembiol.2014.11.012 Chem Biol 2015
Inhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazides. doi:10.1002/cbic.201300748 names it Chembiochem 2014
Design and synthesis of potential mechanism-based inhibitors of the aminotransferase BioA involved in biotin biosynthesis. doi:10.1021/jo3008435 names it J Org Chem 2012
Use of differential scanning fluorimetry to optimize the purification and crystallization of PLP-dependent enzymes. doi:10.1107/S1744309112012912 Acta Crystallogr Sect F Struct Biol Cryst Commun 2012
Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis. doi:10.1021/ja204036t names it J Am Chem Soc 2011
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression. doi:10.1371/journal.ppat.1002264 PLoS Pathog 2011
A continuous fluorescence displacement assay for BioA: an enzyme involved in biotin biosynthesis. doi:10.1016/j.ab.2011.05.003 names it Anal Biochem 2011
Discovery of small molecule probe that shows anti-tubercular activity via Mtb bioA (DAPA synthase) enzyme inhibition. names it 2010
7,8-Diaminoperlargonic acid aminotransferase from Mycobacterium tuberculosis, a potential therapeutic target. Characterization and inhibition studies. doi:10.1111/j.1742-4658.2006.05479.x FEBS J 2006
Identification of the cobalamin-dependent methionine synthase gene, metH, in Vibrio fischeri ATCC 7744 by sequencing using genomic DNA as a template. doi:10.1016/s0378-1119(01)00339-0 Gene 2001

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourbioF (Rv1569, + strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Post-translational modifications

1 reported modified residue(s): N6-(pyridoxal phosphate)lysine @283.

Experimentally reported post-translational modification(s). A phosphosite indicates the protein is expressed and is a substrate of the M. tuberculosis Ser/Thr/Tyr kinase signalling network — a regulatory context, NOT a molecular function. Source: UniProt (Modified residue features; PTM sites curated from the M. tuberculosis literature).

Transcriptional start site (informative, coordinates unchanged)

Primary TSS at position 1775164 (+ strand), 192 bp 5'UTR. TSS-derived candidate start codon: 1775356 -- candidate only, not applied to this record's coordinates.

Genome-wide 5'-triphosphate-enriched RNA-seq TSS mapping (Cortes et al. 2013): informative context on transcript architecture only. reannotated_start_candidate is the authors' TSS-derived candidate start codon -- reported for information, NEVER applied to this atlas's start_mtbc0/end_mtbc0 coordinates (P19 MTBC0<->H37Rv anchoring). Row re-keyed to this locus by matching its genomic boundary against the H37Rv GFF3 (P49.1 (phase233, 2026-09-15), P49): the original ingestion (P16.23/phase135, 2026-08-17) trusted the source table's own gene-identity column, which was desynchronised from its own numeric columns on 547/651 checkable rows -- see P49 for the full diagnostic. A missing primary_tss here means this gene falls outside the 680-gene re-annotation-candidate subset the source table covers, not an absence of transcription. Source: Cortes et al. 2013 (Cell Reports), Table S3 (TSS mapping and re-annotation of start codons), 680-gene re-annotation-candidate subset of >4,000 genome-wide TSS -- row re-keyed to this locus by coordinate match (P49).

CRISPRi vulnerability

Vulnerability index -0.24 (95% CI -0.33 to -0.14). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain (their own confidence call, not a p-value threshold). Its guide library did sample a range of repression strengths (str_span=0.908 on a 0-1 scale, thanks to at least one guide <=18 nt; n_guides=83 descriptive only), so the dose-response fit is not starved of titration the way most 'not certain' genes are -- the uncertainty here is the authors' own confidence call on the fit, not a design limitation of the guide library. Do not cite this VI as a standalone vulnerability claim without checking `certain` first.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in bioconversion of pimelate into dethiobiotin [catalytic activity: S-adenosyl-L-methionine + 8-amino-7- oxononanoate = S-adenosyl-4-methylthio-2-oxobutanoate + 7,8- diaminononanoate]. Supposedly involved in stationary-phase survival.
Mycobrowser EC 2.6.1.62 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1595 · 100.0% identity
M. leprae ML1216 · 85.1% identity
M. marinum MMAR_2383 · 83.9% identity
M. smegmatis MSMEG_3188 · 75.1% identity
M. orygis RJtmp_001656 · 100.0% identity
M. abscessus MAB_2688c · 70.8% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WQ81 SwissProt · reviewed · Evidence at protein level
UniProt nameAdenosylmethionine-8-amino-7-oxononanoate aminotransferase
EC (curated) EC 2.6.1.62
Curated functionCatalyzes the reversible transfer of the alpha-amino group from S-adenosyl-L-methionine (SAM) to 7-keto-8-aminopelargonic acid (KAPA) to form 7,8-diaminopelargonic acid (DAPA). It is the only aminotransferase known to utilize SAM as an amino donor. Can also use sinefungin but not S-adenosylhomocysteine as substrate.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category H Coenzyme transport and metabolism
Preferred namebioA
eggNOG descriptionCatalyzes the transfer of the alpha-amino group from S- adenosyl-L-methionine (SAM) to 7-keto-8-aminopelargonic acid (KAPA) to form 7,8-diaminopelargonic acid (DAPA). It is the only animotransferase known to utilize SAM as an amino donor
Orthologous groupCOG0161
EC number EC 2.6.1.62
KEGG orthology K00833
KEGG pathways map00780, map01100
KEGG modules M00123, M00573, M00577
Gene Ontology (47) GO:0003674, GO:0003824, GO:0004015, GO:0006082, GO:0006732, GO:0006766, GO:0006767, GO:0006768, GO:0006790, GO:0006807, GO:0008150, GO:0008152 +35 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.235 · purifying
Polymorphic sites (≥ 0.1% of strains) 6 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.151 · 20 consensus substitution(s)
under purifying selection vs M. canettii (deep divergence; dN/dS=0.151) — a real, constrained gene predating the MTBC clonal expansion
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 83.9% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 11/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 56.9%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 16 in the ORF — 0 in the essential state, 0 growth-defect, 16 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 126.5. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 16 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required
fitness in mouse infection (in vivo) -7.710.0 required

Conditional fitness of transposon-disruption mutants across 75 significant condition(s) — the table lists the 12 strongest by |log2FC|, not all 75 (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 14 of 16 independent MS datasets
Integrated abundance69.8 ppm · rank 1535/3519 (56.4th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length437 aa
Molecular weight46.3 kDa
Theoretical pI5.82
GRAVY0.306 (hydrophobic)
Aliphatic index98.3
Aromaticity0.071
Instability index38.2 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Aminotran_3PF00202.28 2.4e-11035–428 Aminotransferase class-III

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 4wyd (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 20 solved

PDBMethodResolutionCoverage
4wyd X-ray diffraction 1.35 Å 100%
4xjo X-ray diffraction 1.5 Å 100%
4xjm X-ray diffraction 1.6 Å 100%
4xjp X-ray diffraction 1.6 Å 100%
4wyg X-ray diffraction 1.62 Å 100%
4cxr X-ray diffraction 1.7 Å 100%
4mqq X-ray diffraction 1.7 Å 100%
4wye X-ray diffraction 1.75 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (20 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.6

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
3tft-assembly1_A 1.00 0.99 0.96 0.99 99% 97% / 100% 2.6e-72 sig 3tft-assembly1_A Crystal structure of 7,8-diaminopelargonic acid synthase (BioA) from Mycobacterium tuberculosis, pre-reaction complex with a 3,6-dihydropyrid-2-one heterocycle inhibitor
4cxq-assembly1_B 1.00 0.99 0.97 0.99 100% 98% / 100% 3.4e-72 sig 4cxq-assembly1_B Mycobaterium tuberculosis transaminase BioA complexed with substrate KAPA
4cxq-assembly1_A 1.00 0.99 0.97 0.99 100% 98% / 100% 4.1e-72 sig 4cxq-assembly1_A Mycobaterium tuberculosis transaminase BioA complexed with substrate KAPA
4mqr-assembly1_B 1.00 0.99 0.97 0.99 100% 98% / 100% 3.6e-71 sig 4mqr-assembly1_B Mycobaterium tuberculosis transaminase BioA complexed with E)-5-hydroxy-4-(((Z)-isonicotinoyldiazenyl)methylene)-6-methyl-1,4-dihydropyridin-3-yl)methyl phosphate
6ge8-assembly1_A 1.00 0.99 0.96 0.99 98% 98% / 100% 1.3e-70 sig 6ge8-assembly1_A Crystal structure of Mycobacterium tuberculosis BioA

Foldseek search of the AlphaFold DB model (mean pLDDT 95.6, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 4

Upstream (5' on genome)Rv1567c (- strand, 247 bp gap)
Downstream (3' on genome)bioF1 (+ strand, -4 bp gap)
Predicted operon bioA · bioF1 · bioD · Rv1571

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton) — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1619) exponential phase: operon of 4, Rv1568 · Rv1569 · Rv1570 · Rv1571 (coverage 8.72)
not expressed (stationary phase) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv0767c (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: bioD (ATP-dependent dethiobiotin synthetase BioD), high confidence (score 999, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 22 partners at medium confidence (10 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 22 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1570 bioD curated ATP-dependent dethiobiotin synthetase BioD 999 999 ctx neighborhood:881 cooccurence:762 coexpression:695 database:900 textmining:965
Rv1569 bioF1 curated 8-amino-7-oxononanoate synthase 999 998 ctx neighborhood:881 cooccurence:667 coexpression:473 database:900 textmining:946
Rv1589 bioB biotin synthetase 999 976 ctx fusion:633 cooccurence:756 coexpression:693 textmining:963
Rv0032 bioF2 curated 8-amino-7-oxononanoate synthase 989 974 ctx cooccurence:510 coexpression:451 database:900 textmining:596
Rv1571 hypothetical protein 975 882 ctx neighborhood:881 textmining:803
Rv1567c membrane protein 718 719 ctx neighborhood:719
Rv1563c treY maltooligosyl trehalose synthase 635 625 ctx neighborhood:623
Rv1565c acyltransferase 439 439 ctx neighborhood:439
Rv1564c treX maltooligosyl trehalose synthase 440 428 ctx neighborhood:426
Rv1590 hypothetical protein 401 370
Rv2794c pptT 4'-phosphopantetheinyl transferase 668 260 textmining:571
Rv2438c nadE glutamine-dependent NAD(+) synthetase 887 189 textmining:867
Rv0089 methyltransferase 828 134 textmining:811
Rv3602c panC pantothenate synthetase 808 106 textmining:795
Rv3279c birA bifunctional biotin operon repressor/biotin--[acetyl-CoA-carboxylase 768 102 textmining:753

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: adenosylmethionine--8-amino-7-oxononanoate aminotransferase BioA
  • MTBC0 PGAP product: adenosylmethionine--8-amino-7-oxononanoate transaminase
  • Pfam (hmmscan --cut_ga): Aminotran_3 PF00202.28 (E=2e-110)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216084.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Aminotran_3 (PF00202.28)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0161
  • Curated reference: UniProt P9WQ81 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.6)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 22 functional partner(s); context anchor bioD
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_001676|Rv1568|bioA
MAAATGGLTPEQIIAVDGAHLWHPYSSIGREAVSPVVAVAAHGAWLTLIRDGQPIEVLDAMSSWWTAIHGHGHPALDQALTTQLRVMNHVMFGGLTHEPAARLAKLLVDITPAGLDTVFFSDSGSVSVEVAAKMALQYWRGRGLPGKRRLMTWRGGYHGDTFLAMSICDPHGGMHSLWTDVLAAQVFAPQVPRDYDPAYSAAFEAQLAQHAGELAAVVVEPVVQGAGGMRFHDPRYLHDLRDICRRYEVLLIFDEIATGFGRTGALFAADHAGVSPDIMCVGKALTGGYLSLAATLCTADVAHTISAGAAGALMHGPTFMANPLACAVSVASVELLLGQDWRTRITELAAGLTAGLDTARALPAVTDVRVCGAIGVIECDRPVDLAVATPAALDRGVWLRPFRNLVYAMPPYICTPAEITQITSAMVEVARLVGSLP